{"id":"metformin-alone","safety":{"commonSideEffects":[{"rate":"20-30","effect":"Gastrointestinal disturbance (nausea, diarrhea, abdominal discomfort)"},{"rate":"3-5","effect":"Metallic taste"},{"rate":"10-30","effect":"Vitamin B12 deficiency"},{"rate":"<0.1","effect":"Lactic acidosis (rare, in renal impairment)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Metformin decreases gluconeogenesis in the liver and enhances glucose uptake and utilization in peripheral tissues, primarily through AMPK activation. It also improves insulin sensitivity and may have indirect effects on mitochondrial function and metabolic pathways. The drug does not stimulate insulin secretion, making it weight-neutral and suitable for use across a broad range of glucose levels.","oneSentence":"Metformin reduces hepatic glucose production and improves insulin sensitivity by activating AMP-activated protein kinase (AMPK).","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:20:55.168Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 2 diabetes mellitus"},{"name":"Prediabetes (prevention of progression to type 2 diabetes)"}]},"trialDetails":[{"nctId":"NCT06899061","phase":"PHASE1","title":"Modular Clinical Pharmacology Study to Evaluate the Drug-drug Interaction Potential and Relative Bioavailability of Saruparib","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2025-03-25","conditions":"Advanced Solid Malignancies","enrollment":41},{"nctId":"NCT06907472","phase":"NA","title":"Diabetes Management for Primary Healthcare Centers.","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Abuja","startDate":"2025-09-15","conditions":"Type 2 Diabetes Mellitus (T2DM)","enrollment":106},{"nctId":"NCT04930744","phase":"PHASE2","title":"Safety and Tolerability of Metformin in People With Tuberculosis (TB) and Human Immunodeficiency Virus (HIV)","status":"COMPLETED","sponsor":"University of Massachusetts, Worcester","startDate":"2021-08-26","conditions":"Tuberculosis, Pulmonary Tuberculosis, HIV Coinfection","enrollment":112},{"nctId":"NCT07460336","phase":"NA","title":"Effects of Cofrogliptin on Beta-Cell Function in LADA Patients","status":"NOT_YET_RECRUITING","sponsor":"Second Xiangya Hospital of Central South University","startDate":"2026-03-15","conditions":"Latent Autoimmune Diabetes in Adults (LADA)","enrollment":84},{"nctId":"NCT02365597","phase":"PHASE2","title":"An Efficacy and Safety Study of Erdafitinib (JNJ-42756493) in Participants With Urothelial Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2015-04-22","conditions":"Urothelial Cancer","enrollment":239},{"nctId":"NCT07469254","phase":"NA","title":"Adding 1% Metformin Gel to Bone Graft in Association With Immediate Dental Implants","status":"COMPLETED","sponsor":"Al-Azhar University","startDate":"2022-11-01","conditions":"Metformin Gel, Bone Graft, Immediate Dental Implants","enrollment":20},{"nctId":"NCT03006172","phase":"PHASE1","title":"To Evaluate the Safety, Tolerability, and Pharmacokinetics of Inavolisib Single Agent in Participants With Solid Tumors and in Combination With Endocrine and Targeted Therapies in Participants With Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Genentech, Inc.","startDate":"2016-12-13","conditions":"Breast Cancer, Solid Tumor","enrollment":200},{"nctId":"NCT02946996","phase":"PHASE2","title":"Study of Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients Receiving Androgen Deprivation Therapy","status":"TERMINATED","sponsor":"Medical University of South Carolina","startDate":"2016-12-28","conditions":"Prostate Cancer","enrollment":41},{"nctId":"NCT07446400","phase":"PHASE1","title":"A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuvastatin, and Methotrexate When Administered Together","status":"NOT_YET_RECRUITING","sponsor":"Otsuka Pharmaceutical Development & Commercialization, Inc.","startDate":"2026-03-20","conditions":"Healthy Volunteers","enrollment":48},{"nctId":"NCT03710343","phase":"PHASE2","title":"Metformin for Motor and Cognitive Improvement in Children With Cerebral Palsy: A Feasibility Study","status":"COMPLETED","sponsor":"Holland Bloorview Kids Rehabilitation Hospital","startDate":"2023-11-14","conditions":"Cerebral Palsy","enrollment":3},{"nctId":"NCT04416269","phase":"PHASE4","title":"Oral Anti Diabetic Agents in the Hospital","status":"ACTIVE_NOT_RECRUITING","sponsor":"Emory University","startDate":"2020-08-07","conditions":"Diabetes Mellitus","enrollment":255},{"nctId":"NCT03934021","phase":"","title":"Gut Microbiota in Acute Stroke Patients","status":"COMPLETED","sponsor":"Chinese University of Hong Kong","startDate":"2018-07-01","conditions":"Stroke, Stroke, Acute, Stroke, Ischemic","enrollment":120},{"nctId":"NCT07141342","phase":"NA","title":"Fast In-Bed Tracking (FIT) System Lifestyle Intervention is a Clinical Trial of a Bed Scale Device. Overweight Wheelchair Users Will Participate in a Weight Loss Program, Half Will Receive Bed Scales, and Participants Who Receive the Bed Scales Are Expected to Have Increased Weight Loss.","status":"RECRUITING","sponsor":"Jonathan Pearlman","startDate":"2026-02-16","conditions":"Disability Physical, Wheelchair, Obesity; Overweight","enrollment":92},{"nctId":"NCT07417306","phase":"PHASE3","title":"A Study of HDM1005 in Participants With T2DM Not Controlled With Metformin Alone or in Combination With a Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor","status":"NOT_YET_RECRUITING","sponsor":"Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.","startDate":"2026-03-27","conditions":"Type 2 Diabetes","enrollment":912},{"nctId":"NCT07412015","phase":"NA","title":"Pilot Bioequivalence Study of Chiglitazar/Metformin Extended-Release Tablets","status":"NOT_YET_RECRUITING","sponsor":"Chipscreen Biosciences, Ltd.","startDate":"2026-05-27","conditions":"T2DM (Type 2 Diabetes Mellitus)","enrollment":24},{"nctId":"NCT07415226","phase":"","title":"Glucose-lowering Drugs as an Adjunct to Insulin Therapy in Chinese Patients With Type 1 Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine","startDate":"2026-05-01","conditions":"Type 1 Diabetes Mellitus","enrollment":500},{"nctId":"NCT05743387","phase":"NA","title":"Community-based, eHealth Supported Type 2 Diabetes Care by Lay Village Health Workers in Rural Lesotho","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2023-05-13","conditions":"Type 2 Diabetes Mellitus (T2D)","enrollment":252},{"nctId":"NCT07158411","phase":"PHASE1","title":"Evaluate the Effect of Vimseltinib on Organic Cation Transporter 2 (OCT2)","status":"COMPLETED","sponsor":"Deciphera Pharmaceuticals, LLC","startDate":"2025-11-20","conditions":"Healthy Participants","enrollment":22},{"nctId":"NCT07222098","phase":"PHASE1","title":"A Clinical Study of Calderasib (MK-1084) With Rosuvastatin and Metformin in Healthy People (MK-1084-016)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-11-19","conditions":"Healthy","enrollment":16},{"nctId":"NCT07399470","phase":"PHASE1","title":"A Clinical Study in Healthy Adults to See How the Body Processes and How Safe a Tablet That Combines Gemigliptin, Dapagliflozin, and Metformin is, Compared With Taking Zemiglo and Xigduo XR Together While Fasting.","status":"ACTIVE_NOT_RECRUITING","sponsor":"LG Chem","startDate":"2026-01-09","conditions":"Healthy Volunteers, Fasting Conditions","enrollment":58},{"nctId":"NCT07395960","phase":"PHASE1, PHASE2","title":"The Efficacy and Safety of Metformin Intervention in Elderly Overweight or Obesity With Mild Cognitive Impairment","status":"RECRUITING","sponsor":"Fudan University","startDate":"2025-09-01","conditions":"Mild Cognitive Impairment, Overweight or Obesity, Elderly","enrollment":54},{"nctId":"NCT07396844","phase":"PHASE1","title":"The Food Effect on Pharmacokinetics of Fixed Dose Combination of Gemigliptin/Dapagliflozin/Metformin in Healthy Volunteers","status":"NOT_YET_RECRUITING","sponsor":"LG Chem","startDate":"2026-07-01","conditions":"Healthy, Fasting, Fed","enrollment":28},{"nctId":"NCT06961019","phase":"NA","title":"Clinical Study to Assess the Safety, Efficacy and In-Use Tolerability of Herbal-Based Sugar Support Effervescent Tablets in Type-2 Diabetes Mellitus Patients","status":"RECRUITING","sponsor":"NovoBliss Research Pvt Ltd","startDate":"2025-08-25","conditions":"Type2 Diabetes Mellitus","enrollment":14},{"nctId":"NCT07380841","phase":"NA","title":"Metformin vs Inositol vs Diet vs Combination Therapy in PCOS","status":"COMPLETED","sponsor":"Islamabad Medical and Dental College","startDate":"2025-05-21","conditions":"Polycystic Ovary Syndrome, Insulin Resistance, Metabolic Syndrome","enrollment":192},{"nctId":"NCT07244770","phase":"","title":"The Effects of Some Antihyperglycemic Drugs on Cognitive Function and Risk of Depression of Diabetic Patients","status":"RECRUITING","sponsor":"Beni-Suef University","startDate":"2025-01-01","conditions":"MCI","enrollment":300},{"nctId":"NCT07375654","phase":"PHASE1","title":"Combined Use of Cyclosporine and Metformin in Treatment of Psoriasis vs Cyclosporine Alone","status":"COMPLETED","sponsor":"Cairo University","startDate":"2024-12-19","conditions":"Psoriasis","enrollment":32},{"nctId":"NCT07372118","phase":"PHASE1","title":"Bioequivalence Study to Compare Empagliflozin / Metformin 25 mg/ 1000 mg Extended-Release Tablet Versus Synjardy XR Tablets 25mg/1000mg in Fast Condition","status":"COMPLETED","sponsor":"Humanis Saglık Anonim Sirketi","startDate":"2025-09-27","conditions":"Type 2 Diabetes Mellitus (T2DM)","enrollment":32},{"nctId":"NCT07120971","phase":"EARLY_PHASE1","title":"Metformin for Premature Infants With Bronchopulmonary Dysplasia","status":"RECRUITING","sponsor":"Medical College of Wisconsin","startDate":"2025-12-19","conditions":"Bronchopulmonary Dysplasia (BPD)","enrollment":40},{"nctId":"NCT05164263","phase":"PHASE4","title":"Real World Safety & Efficacy Experience of Empagliflozin With or Without Metformin in T2DM Patients - EASE Study","status":"RECRUITING","sponsor":"Getz Pharma","startDate":"2021-04-01","conditions":"Type II Diabetes Mellitus, Efficacy, Self, Safety Issues","enrollment":2000},{"nctId":"NCT05230758","phase":"PHASE3","title":"Effect of Metformin on Behaviour and the Brain in Children Treated for a Brain Tumour","status":"RECRUITING","sponsor":"Donald Mabbott","startDate":"2022-07-01","conditions":"Medulloblastoma, Childhood, Cognitive Impairment","enrollment":140},{"nctId":"NCT02087826","phase":"NA","title":"Study of Clinical Response to Acute Metformin By Leveraging Evaluations During a Mixed Meal Tolerance Test for Exploring Glycemia and GeneticS","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2014-04","conditions":"Genetics, Metabolism, Type 2 Diabetes","enrollment":1017},{"nctId":"NCT07336914","phase":"NA","title":"Effect of Conventional vs Intensive Management on Gestational Diabetes and Maternal Fetal Outcomes","status":"RECRUITING","sponsor":"Khyber Medical University Peshawar","startDate":"2025-10-01","conditions":"Gestational Diabetes","enrollment":60},{"nctId":"NCT05741372","phase":"NA","title":"A Study to Compare How Different Medicines (Rosuvastatin, Digoxin, Metformin, and Furosemide) Are Handled by the Body of Healthy People and People With Liver Cirrhosis","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2023-09-07","conditions":"Liver Cirrhosis","enrollment":28},{"nctId":"NCT07333742","phase":"PHASE1","title":"A Clinical Study to See How the Body Handles and How Safe a Combination Tablet of Gemigliptin, Dapagliflozin, and Metformin 50/10/1000mg is Compared to Taking Gemigliptin 50mg Separately With Dapagliflozin/Metformin 10/1000mg in Healthy Adults After a Meal","status":"COMPLETED","sponsor":"LG Chem","startDate":"2025-09-29","conditions":"Fed Conditions, Healthy Volunteer","enrollment":50},{"nctId":"NCT07331389","phase":"PHASE1","title":"A Drug-Drug Interaction Study of HDM1002 and Metformin, Empagliflozin, Midazolam, Valsartan, and Warfarin","status":"RECRUITING","sponsor":"Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.","startDate":"2025-09-24","conditions":"Overweight Subject, Healthy Subjects","enrollment":111},{"nctId":"NCT07216131","phase":"PHASE1","title":"A Study to Investigate the Effect of AZD0780 on Metformin Pharmacokinetics in Healthy Adult Volunteers Aged 18 to 55 Years","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2025-11-10","conditions":"Healthy Participants","enrollment":14},{"nctId":"NCT07323589","phase":"PHASE3","title":"Impact of Myo-Inositol Alone vs Myo-Inositol Plus Metformin on Conception, Adherence, and Tolerability in PCOS","status":"COMPLETED","sponsor":"PAEC general hospital","startDate":"2025-01-01","conditions":"PCOS (Polycystic Ovary Syndrome)","enrollment":120},{"nctId":"NCT07307677","phase":"NA","title":"Melatonin & Metformin on Clinical & Biochemical Parameters in Insulin Resistant PCOS Compared to Metformin","status":"RECRUITING","sponsor":"Mst.Sumyara Khatun","startDate":"2025-03-11","conditions":"PCOS(Insulin Resistant)","enrollment":60},{"nctId":"NCT06445946","phase":"PHASE4","title":"DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes","status":"RECRUITING","sponsor":"Ohio State University","startDate":"2024-08-01","conditions":"Gestational Diabetes Mellitus, Pregnancy, High Risk","enrollment":1572},{"nctId":"NCT07321223","phase":"NA","title":"Comparison of Different Doses of Vitamin D Supplementation on Glycated Haemoglobin and Blood Glucose Parameters With Type II Diabetes Mellitus Having Vitamin d Deficiency","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Lahore","startDate":"2024-08-22","conditions":"Diabetes (DM), Vitamin D Deficiency","enrollment":108},{"nctId":"NCT06415773","phase":"PHASE3","title":"Effects of Berberine Ursodeoxycholate (HTD1801) Versus Dapagliflozin in Patients With Type 2 Diabetes Inadequately Controlled With Metformin","status":"COMPLETED","sponsor":"HighTide Biopharma Pty Ltd","startDate":"2024-06-04","conditions":"T2DM (Type 2 Diabetes Mellitus)","enrollment":367},{"nctId":"NCT07300033","phase":"PHASE1","title":"Bioequivalence Study of Liquid Metformin (100 and 250 mg/mL) vs IR Tablets","status":"NOT_YET_RECRUITING","sponsor":"Aspargo Labs, Inc","startDate":"2026-05-15","conditions":"Healthy Volunteer","enrollment":24},{"nctId":"NCT07300020","phase":"PHASE1","title":"PK and Relative Bioavailability of Novel Liquid Metformin vs Tablets","status":"NOT_YET_RECRUITING","sponsor":"Aspargo Labs, Inc","startDate":"2026-04-15","conditions":"Healthy Volunteer","enrollment":24},{"nctId":"NCT07300059","phase":"PHASE1","title":"Short-Term Glycemic Effects of Liquid Metformin vs Standard Tablets","status":"NOT_YET_RECRUITING","sponsor":"Aspargo Labs, Inc","startDate":"2026-07-15","conditions":"Healthy Volunteers","enrollment":24},{"nctId":"NCT07300046","phase":"PHASE1","title":"Tolerability Study of Liquid Metformin (100 and 250 mg/mL) vs IR Tablets","status":"NOT_YET_RECRUITING","sponsor":"Aspargo Labs, Inc","startDate":"2026-06-15","conditions":"Healthy Volunteers","enrollment":24},{"nctId":"NCT07300007","phase":"PHASE1","title":"PK and Relative Bioavailability of Liquid Metformin vs Tablets in Healthy Adults","status":"NOT_YET_RECRUITING","sponsor":"Aspargo Labs, Inc","startDate":"2026-03-15","conditions":"Healthy Volunteer","enrollment":24},{"nctId":"NCT04691960","phase":"PHASE2","title":"A Pilot Study of Ketogenic Diet and Metformin in Glioblastoma: Feasibility and Metabolic Imaging","status":"ACTIVE_NOT_RECRUITING","sponsor":"Weill Medical College of Cornell University","startDate":"2016-08","conditions":"Glioblastoma","enrollment":18},{"nctId":"NCT05838573","phase":"PHASE3","title":"Metformin Treatment on Cognitive Impairment of Schizophrenia","status":"RECRUITING","sponsor":"Central South University","startDate":"2023-05-08","conditions":"Schizophrenia","enrollment":120},{"nctId":"NCT06983223","phase":"NA","title":"Oral Sucrosomial® Vitamin B12 in the Management of B12 Deficiency Among Metformin-Treated Type 2 Diabetes Patients","status":"COMPLETED","sponsor":"Liaquat University of Medical & Health Sciences","startDate":"2025-08-15","conditions":"Vitamin B 12 Deficiency, Type 2 Diabetes Mellitus (T2DM)","enrollment":50},{"nctId":"NCT06185179","phase":"EARLY_PHASE1","title":"Metformin and Muscle Recovery","status":"RECRUITING","sponsor":"University of Utah","startDate":"2024-09-01","conditions":"Muscle Atrophy or Weakness","enrollment":50},{"nctId":"NCT07266766","phase":"PHASE1","title":"Bioequivalence Study to Compare Empagliflozin / Metformin 25 mg/ 1000 mg Extended-Release Tablet Versus Synjardy XR Tablets 25mg/1000mg","status":"COMPLETED","sponsor":"Humanis Saglık Anonim Sirketi","startDate":"2025-08-05","conditions":"Type 2 Diabetes Mellitus (T2DM)","enrollment":40},{"nctId":"NCT03107884","phase":"EARLY_PHASE1","title":"Role of Metformin on Muscle Health of Older Adults","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Utah","startDate":"2019-08-01","conditions":"Muscle Atrophy, Insulin Resistance","enrollment":64},{"nctId":"NCT05064488","phase":"PHASE1","title":"Drug-Drug Interaction Study of Evobrutinib and Transporter Substrates","status":"COMPLETED","sponsor":"Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany","startDate":"2021-10-04","conditions":"Healthy","enrollment":40},{"nctId":"NCT07266779","phase":"PHASE1","title":"Bioequivalence Study of Test Product (T) of Ertugliflozin/Metformin 7.5 mg/ 1000 mg Film Coated Tablets and Reference Product (R) of Segluromet 7.5 mg/ 1000 mg Film Coated Tablets in Healthy, Adult, Human Subjects Under Fed Condition.","status":"COMPLETED","sponsor":"Humanis Saglık Anonim Sirketi","startDate":"2025-08-22","conditions":"Type 2 Diabetes","enrollment":36},{"nctId":"NCT05515978","phase":"EARLY_PHASE1","title":"Pragmatic Trial of Metformin for Glucose Intolerance or Increased BMI in Prostate Cancer Patients","status":"RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2022-10-10","conditions":"Prostate Cancer","enrollment":100},{"nctId":"NCT04220021","phase":"PHASE2","title":"Safety and Therapeutic Potential of the FDA-approved Drug Metformin for C9orf72 ALS/FTD","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Florida","startDate":"2020-01-10","conditions":"C9orf72 Amyotrophic Lateral Sclerosis (ALS), Frontotemporal Dementia","enrollment":41},{"nctId":"NCT06688123","phase":"PHASE2","title":"Efficacy and Safety of SHR-3167 and Insulin Glargine in Type 2 Diabetes Subjects","status":"ACTIVE_NOT_RECRUITING","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","startDate":"2025-01-08","conditions":"Type 2 Diabetes","enrollment":275},{"nctId":"NCT07241897","phase":"PHASE3","title":"DPP4 Inhibitor Intervention on Post-stroke Cognitive Impairment in Ischemic Stroke Patients With Type 2 Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital of Soochow University","startDate":"2025-12-15","conditions":"Ischemic Stroke, Diabete Mellitus","enrollment":312},{"nctId":"NCT04945148","phase":"PHASE2","title":"Oxidative Phosphorylation Targeting In Malignant Glioma Using Metformin Plus Radiotherapy Temozolomide","status":"RECRUITING","sponsor":"Hopital Foch","startDate":"2024-05-10","conditions":"Glioblastoma, IDH-wildtype","enrollment":640},{"nctId":"NCT06889454","phase":"","title":"Cardiovascular and Endothelial Markers During OGTT Before and at Six and Twelve Months Post-treatment in Women With PCOS","status":"RECRUITING","sponsor":"Attikon Hospital","startDate":"2024-02-01","conditions":"PCOS, Hyperinsulinism, Hyperandrogenism","enrollment":120},{"nctId":"NCT07098299","phase":"PHASE1","title":"Metformin Combined With Chemotherapy and/or Immunotherapy in Solid Malignancies","status":"RECRUITING","sponsor":"Barbara Ann Karmanos Cancer Institute","startDate":"2025-09-18","conditions":"Advanced Solid Tumor","enrollment":60},{"nctId":"NCT01797523","phase":"PHASE2","title":"A Phase II, Single-Arm Study of RAD001 (Everolimus), Letrozole, and Metformin in Patients With Advanced or Recurrent Endometrial Carcinoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2013-10-07","conditions":"Endometrial Cancer","enrollment":62},{"nctId":"NCT03229057","phase":"PHASE3","title":"Comparing the Effects of Oral Contraceptive Pills Versus Metformin","status":"COMPLETED","sponsor":"Anuja Dokras","startDate":"2018-01-15","conditions":"PCOS","enrollment":240},{"nctId":"NCT07121959","phase":"PHASE1","title":"A Study of Belzutifan (MK-6482) and Metformin in Healthy Adult Participants (MK-6482-039)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-08-18","conditions":"Healthy","enrollment":14},{"nctId":"NCT07215156","phase":"NA","title":"Metformin Versus Chlorhexidine Gel as Adjuncts to Scaling and Root Planing in Stage II Grade B Periodontitis","status":"NOT_YET_RECRUITING","sponsor":"Kafrelsheikh University","startDate":"2025-10-06","conditions":"Stage II, Grade B Periodontitis, Chronic Periodontitis","enrollment":60},{"nctId":"NCT07213895","phase":"PHASE1","title":"Bioequivalence Study to Compare Empagliflozin/Linagliptin/Metformin HCL 25mg/5mg/1000mg Extended-Release Tablets Versus Trijardy® XR Extended Release Film Coated Tablets","status":"COMPLETED","sponsor":"Humanis Saglık Anonim Sirketi","startDate":"2025-05-21","conditions":"Type 2 Diabetes Mellitus (T2DM)","enrollment":14},{"nctId":"NCT06479434","phase":"NA","title":"Serum Biomarker Levels Improvement in Poly Cystic Ovarian Syndrome: Impact of Metformin Compared to Healthy Controls","status":"COMPLETED","sponsor":"Aga Khan University","startDate":"2024-06-24","conditions":"Polycystic Ovary Syndrome, Insulin Resistance","enrollment":110},{"nctId":"NCT07026968","phase":"PHASE3","title":"A Study of Prusogliptin Tablets Combined With Dapagliflozin Tablets and Metformin Hydrochloride Extended Release Tablets in Type 2 Diabetes","status":"ENROLLING_BY_INVITATION","sponsor":"CSPC Ouyi Pharmaceutical Co., Ltd.","startDate":"2025-06-20","conditions":"Type 2 Diabetes","enrollment":815},{"nctId":"NCT06813924","phase":"PHASE1","title":"A Research Study of the Effect of Etavopivat on Other Drugs in Healthy Participants","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2025-02-06","conditions":"Healthy Volunteers Sickle Cell Disease, Thalassemia","enrollment":37},{"nctId":"NCT07188740","phase":"PHASE1","title":"Metformin Inhibits DNMT3A Clonal Hematopoiesis in Acute Leukemia","status":"NOT_YET_RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2025-10-30","conditions":"DNMT3A Gene Mutation","enrollment":30},{"nctId":"NCT02710448","phase":"PHASE2","title":"May Metformin be Used in Renal Failure?","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2012-06","conditions":"Renal Disorder Associated With Type II Diabetes Mellitus","enrollment":82},{"nctId":"NCT07165158","phase":"PHASE4","title":"The Effect of Semaglutide on Bone Health","status":"NOT_YET_RECRUITING","sponsor":"The First Affiliated Hospital of Xiamen University","startDate":"2025-09-15","conditions":"Osteoporosis, Osteoporosis Fracture, T2DM","enrollment":150},{"nctId":"NCT06920056","phase":"PHASE1","title":"A Study of BGM0504 in Overweight or Obese Participants","status":"COMPLETED","sponsor":"BrightGene Bio-Medical Technology Co., Ltd.","startDate":"2025-03-24","conditions":"Overweight or Obese","enrollment":28},{"nctId":"NCT07136987","phase":"PHASE3","title":"A Trial of 2 Disease-Modifying Drugs (Metformin and N-acetylcysteine ) to Promote TB Lung Function Recovery","status":"NOT_YET_RECRUITING","sponsor":"Open Source Pharma Foundation","startDate":"2026-01","conditions":"Tuberculosis","enrollment":1104},{"nctId":"NCT07121088","phase":"PHASE4","title":"Traditional Chinese Medicine Intervention for Ischemic Cerebrovascular Disease and Diabetes Mellitus: An Efficacy Comparative Study","status":"NOT_YET_RECRUITING","sponsor":"Guangzhou University of Traditional Chinese Medicine","startDate":"2025-08-31","conditions":"Ischemic Cerebral Infarction, Diabetes Mellitus","enrollment":3666},{"nctId":"NCT06071442","phase":"PHASE1","title":"Potential Drug Interaction Study Between Vemircopan and Rosuvastatin, Metformin, Levonorgestrel/Ethinyl Estradiol-containing Oral Contraceptives, and Carbamazepine","status":"COMPLETED","sponsor":"Alexion Pharmaceuticals, Inc.","startDate":"2024-01-17","conditions":"Healthy Participants","enrollment":60},{"nctId":"NCT05365451","phase":"EARLY_PHASE1","title":"Pharmacokinetic Drug-Drug Interaction Study to Identify Biomarkers of Kidney Transporters","status":"COMPLETED","sponsor":"Washington State University","startDate":"2022-04-11","conditions":"Interaction, Endogenous Biomarkers","enrollment":16},{"nctId":"NCT07108075","phase":"NA","title":"Acute Portal Pressure Reduction by Metformin and Carvedilol Compared to Carvedilol Alone in Cirrhosis.","status":"RECRUITING","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2025-06-14","conditions":"Liver Cirrhosis","enrollment":72},{"nctId":"NCT07088523","phase":"PHASE4","title":"Traditional Chinese Medicine Intervention for Ischemic Cardiovascular Disease Comorbid With Diabetes Mellitus: An Efficacy Comparative Study","status":"NOT_YET_RECRUITING","sponsor":"Guangzhou University of Traditional Chinese Medicine","startDate":"2025-07-31","conditions":"Diabete Mellitus, Ischemic Cardiovascular Disease","enrollment":4205},{"nctId":"NCT05929495","phase":"PHASE2","title":"Phase 2, Open-label, Single-arm Study on the Use of Metformin as Adjunctive Therapy in High-grade Glioma","status":"RECRUITING","sponsor":"University of Milano Bicocca","startDate":"2024-02-12","conditions":"Glioblastoma, IDH-wildtype, Metformin, Malignancies","enrollment":25},{"nctId":"NCT07083401","phase":"PHASE1","title":"A Study to Evaluate the Pharmacokinetics and Safety Between \"BR3006\" and Co-administration of \"BR3006A\", \"BR3006B\", and \"BR3006C\" in Healthy Adult Volunteers (Fed)","status":"RECRUITING","sponsor":"Boryung Pharmaceutical Co., Ltd","startDate":"2025-07-05","conditions":"Diabete Mellitus","enrollment":40},{"nctId":"NCT07083388","phase":"PHASE1","title":"A Study to Evaluate the Pharmacokinetics and Safety Between \"BR3006\" and Co-administration of \"BR3006A\", \"BR3006B\", and \"BR3006C\" in Healthy Adult Volunteers (Fasting)","status":"RECRUITING","sponsor":"Boryung Pharmaceutical Co., Ltd","startDate":"2025-07-03","conditions":"Diabetes Mellitus","enrollment":52},{"nctId":"NCT02879409","phase":"NA","title":"HbA1c Variability in Type II Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"Weill Cornell Medical College in Qatar","startDate":"2016-11","conditions":"Diabetes Mellitus Type 2","enrollment":150},{"nctId":"NCT07072949","phase":"PHASE1","title":"The Impact of Ursodeoxycholic Acid and Probiotics on Metabolic Outcomes in Type 2 Diabetic Patients Taking Metformin","status":"COMPLETED","sponsor":"University of Banja Luka","startDate":"2023-01-03","conditions":"Type 2 Diabetes Mellitus","enrollment":90},{"nctId":"NCT07065591","phase":"EARLY_PHASE1","title":"Anti-Diabetic Drug, Exercise and Healthy Diet for Knee Osteoarthritis With Overweight/Obesity","status":"NOT_YET_RECRUITING","sponsor":"The University of Hong Kong","startDate":"2025-10-01","conditions":"Osteoarthritis (OA) of the Knee","enrollment":100},{"nctId":"NCT06804187","phase":"","title":"Sweet Sensing in Type 2 Diabetes","status":"ENROLLING_BY_INVITATION","sponsor":"University of Nottingham","startDate":"2025-02-01","conditions":"Type 2 Diabetes, Prediabetes","enrollment":505},{"nctId":"NCT06679413","phase":"PHASE1","title":"A Study to Assess Drug-drug Interaction of ZX008 in Healthy Male and Female Study Participants","status":"COMPLETED","sponsor":"UCB BIOSCIENCES, Inc.","startDate":"2024-12-04","conditions":"Healthy Study Participants","enrollment":22},{"nctId":"NCT07044765","phase":"PHASE1","title":"A Study to Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy Adults: Fed State Study","status":"NOT_YET_RECRUITING","sponsor":"AJU Pharm Co., Ltd.","startDate":"2025-08","conditions":"Type2 Diabetes Mellitus","enrollment":32},{"nctId":"NCT04972396","phase":"PHASE1","title":"Pemvidutide (ALT-801) DDI Study in Healthy Volunteers","status":"COMPLETED","sponsor":"Altimmune, Inc.","startDate":"2021-09-15","conditions":"NASH - Nonalcoholic Steatohepatitis","enrollment":40},{"nctId":"NCT07034781","phase":"PHASE1","title":"A Study to Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy Adults","status":"NOT_YET_RECRUITING","sponsor":"AJU Pharm Co., Ltd.","startDate":"2025-08","conditions":"Type2 Diabetes Mellitus","enrollment":50},{"nctId":"NCT06723691","phase":"PHASE1","title":"Influence of HRS9531 on Gastric Emptying and Pharmacokinetics of Metformin, Atorvastatin, Warfarin, and Digoxin in Healthy Subjects","status":"COMPLETED","sponsor":"Fujian Shengdi Pharmaceutical Co., Ltd.","startDate":"2024-12-18","conditions":"Type 2 Diabetes","enrollment":57},{"nctId":"NCT03675893","phase":"PHASE2","title":"RESOLVE: Abemaciclib + Letrozole +/- Metformin, Zotatifin, or Gedatolisib in Endometrial or Low-Grade Serous Ovarian Cancer","status":"RECRUITING","sponsor":"Dana-Farber Cancer Institute","startDate":"2018-12-24","conditions":"Endometrial Cancer, Ovarian Cancer","enrollment":180},{"nctId":"NCT03686657","phase":"PHASE1, PHASE2","title":"Evaluation of Superiority of Valsartan+Celecoxib+Metformin Over Metformin Alone in Type 2 Diabetes Patients","status":"NOT_YET_RECRUITING","sponsor":"ARKAY Therapeutics","startDate":"2025-10-10","conditions":"Type 2 Diabetes, High Blood Pressure, Arthritis","enrollment":115},{"nctId":"NCT06359015","phase":"PHASE4","title":"Metformin and Esomeprazole in Preterm Pre-eclampsia","status":"TERMINATED","sponsor":"Christiana Care Health Services","startDate":"2021-02-11","conditions":"Preeclampsia Severe, Pre-Eclampsia, Preeclampsia","enrollment":4},{"nctId":"NCT04008186","phase":"PHASE1","title":"A Clinical Drug-Drug Interaction (DDI) Study With Omaveloxolone","status":"COMPLETED","sponsor":"Biogen","startDate":"2019-06-14","conditions":"Healthy Adult Subjects","enrollment":61},{"nctId":"NCT01135433","phase":"PHASE3","title":"A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Metformin in Type 2 Diabetic Patients","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2010-05-15","conditions":"Type 2 Diabetes Mellitus","enrollment":168},{"nctId":"NCT04090580","phase":"PHASE3","title":"Impact on Glycemic Variability in Newly Onset T2DM Patients Initiating Dapagliflozin Plus Metformin Versus Metformin Alone","status":"COMPLETED","sponsor":"Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran","startDate":"2019-10-27","conditions":"Type 2 Diabetes","enrollment":88},{"nctId":"NCT01117584","phase":"PHASE2","title":"A Study to Evaluate the Effect of ASP1941 in Combination With Metformin in Adult Patients With Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2010-04-06","conditions":"Type 2 Diabetes Mellitus","enrollment":343},{"nctId":"NCT06335134","phase":"PHASE1","title":"A Drug-Drug Interaction Study Between XW003 and Metformin, Warfarin, Rosuvastatin or Digoxin","status":"COMPLETED","sponsor":"Hangzhou Sciwind Biosciences Co., Ltd.","startDate":"2023-07-14","conditions":"Healthy Volunteers","enrollment":57},{"nctId":"NCT01762046","phase":"PHASE1","title":"Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2008-01","conditions":"Diabetes Mellitus, Type 2","enrollment":1033}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":883,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["metformin"],"phase":"phase_3","status":"active","brandName":"Metformin alone","genericName":"Metformin alone","companyName":"Mount Sinai Hospital, Canada","companyId":"mount-sinai-hospital-canada","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Metformin is a small molecule medication used to treat Type 2 Diabetes Mellitus (T2DM). It is classified as a small molecule due to its chemical properties.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}